Effectiveness of Ethinylestradiol/Chlormadinone Acetate in Treating Dermatological Conditions Related to High Androgen Levels

    September 2011 in “ American Journal of Clinical Dermatology ”
    A. Guerra‐Tapia, Blanca Sancho Pérez
    Studysummary This review describes the dermatological uses of the contraceptive ethinylestradiol/chlormadinone acetate for conditions linked to high androgen levels and reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 10

    1. Efficacy of an Oral Contraceptive Containing EE 0.03 mg and CMA 2 mg (Belara) in Moderate Acne Resolution: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial Contraception · 2009
    2. Management of Androgenetic Alopecia in Postmenopausal Women Actas Dermo-Sifiliográficas · 2008
    3. Effects of Two Estroprogestins Containing Ethinylestradiol 30 μg and Drospirenone 3 mg and Ethinylestradiol 30 μg and Chlormadinone 2 mg on Skin and Hormonal Hyperandrogenic Manifestations Gynecological endocrinology · 2008
    4. Managing Cutaneous Manifestations of Hyperandrogenic Disorders Treatments in endocrinology · 2002
    5. Acne American journal of clinical dermatology · 2002
    6. Acne Resolution Rates: Results of a Single-Blind, Randomized, Controlled, Parallel Phase III Trial with EE/CMA (Belara®) and EE/LNG (Microgynon®) Dermatology · 2001
    7. Incidence of Female Androgenetic Alopecia (Female Pattern Alopecia) Dermatologic Surgery · 2001
    8. The Psychosocial Consequences of Androgenetic Alopecia: A Review of the Research Literature British Journal of Dermatology · 1999
    9. The Human Sebocyte Culture Model Provides New Insights Into Development and Management of Seborrhoea and Acne Dermatology · 1998
    10. Outcome of Long-Term Treatment with the 5α-Reductase Inhibitor Finasteride in Idiopathic Hirsutism: Clinical and Hormonal Effects During a 1-Year Course of Therapy and 1-Year Follow-Up Fertility and Sterility · 1996

    Related research 2

    1. Effectiveness of Ethinylestradiol/Chlormadinone Acetate in Treating Dermatological Conditions Related to High Androgen Levels American Journal of Clinical Dermatology · 2011
    2. Antiandrogenic Progestins for Treatment of Signs of Androgenisation and Hormonal Contraception European journal of obstetrics, gynecology, and reproductive biology/European journal of obstetrics & gynecology and reproductive biology · 2004